Clinical Trial Update: A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults [Phase 3]

View source ↗

Summary

Phase 3 trial comparing multiple doses of VI-0521 with placebo (and their single-agent constituents) for obesity in adults has completed. Results were posted on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2012-09-03